Track global drug pipelines in real-time across 190+ markets with predictive scoring and competitive intelligence
Our Pipeline Intelligence service provides comprehensive visibility into global drug development pipelines, enabling pharmaceutical companies to make data-driven decisions about R&D investments, competitive positioning, and strategic partnerships.
Leveraging AI-powered analysis of 190+ markets, we deliver real-time insights on drug development phases, success probabilities, and competitive landscapes that help you identify opportunities and mitigate risks.
We continuously ingest pipeline data from 190+ regulatory authorities, clinical trial registries, company disclosures, and scientific publications.
Machine learning models analyze pipeline data to predict phase transitions, success probabilities, and identify competitive threats.
We synthesize multi-source intelligence into actionable insights, competitive benchmarks, and strategic recommendations.
Optimize pipeline investments by identifying high-potential assets and competitive whitespace opportunities.
Monitor competitor pipelines, anticipate launches, and assess competitive threats across therapeutic areas.
Identify licensing opportunities, partnership targets, and M&A candidates with pipeline gap analysis.
Evaluate investment opportunities with comprehensive pipeline risk assessment and market potential analysis.
Pharma Client • 2024
Helped optimize a $2B oncology pipeline by identifying competitive threats and whitespace opportunities, resulting in 30% faster go/no-go decisions.
Biotech Client • 2024
Provided competitive intelligence for rare disease pipeline, identifying 3 high-value partnership opportunities and 2 competitive threats.